PharmaResearch IPO Draws Robust Interest Amid Biotech Boom
This article was originally published in PharmAsia News
Executive Summary
Following a series of successful IPOs by South Korean biopharma firms earlier this year, helped by the ongoing biotech rallies at home and in the U.S., PharmaResearch Products, which focuses on cell and tissue regeneration technology, has priced its shares sharply above the pricing band for its offering.